IMUREL
As listed in the register: IMUREL 50 mg, poudre pour solution injectable (IV)
50 mg · poudre pour solution injectable
- Prescription only
- Active substance
- Azathioprine
- Made by
- ASPEN PHARMA TRADING (IRLANDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Azathioprine). It describes the substance, not this exact product.
Azathioprine is well absorbed following oral administration.
Maximum serum radioactivity occurs at 1 to 2 hours after oral 35 S-azathioprine and decays with a half-life of 5 hours.
Azathioprine is metabolized to 6-mercaptopurine (6-MP).
Both compounds are rapidly eliminated from blood and are oxidized or methylated in erythrocytes and liver; no azathioprine or mercaptopurine is detectable in urine after 8 hours.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-05-05
Safety of the active substance
From the US prescribing label for the same active substance (Azathioprine). It describes the substance, not this exact product.
WARNING-MALIGNANCY Chronic immunosuppression with azathioprine, a purine antimetabolite increases risk of malignancy in humans.
- Azathioprine should not be given to patients who have shown hypersensitivity to the drug.
- Azathioprin should not be used for treating rheumatoid arthritis in pregnant women.
- Patients with rheumatoid arthritis previously treated with alkylating agents (cyclophosphamide, chlorambucil, melphalan, or others) may have a prohibitive risk of malignancy if treated with azathioprine.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | ASPEN PHARMA TRADING (IRLANDE) |
|---|---|
| Active substance | Azathioprine |
| Strength | 50 mg |
| Form | poudre pour solution injectable |
| Route | intraveineuse |
| Dispensing (as stated by the register) | réservé à l'usage HOSPITALIER · liste I |
| Marketed | No — authorised but not currently marketed, according to the register |
| Authorisation procedure | Procédure nationale |
| Name in the register | IMUREL 50 mg, poudre pour solution injectable (IV) |
| Packs | 1 flacon(s) en verre |
| CIS | 63935487 |
| CIP13 | 3400956193653 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- comprimé pelliculé4 products
- 25 mg
50 mg3
50 mg · 3 companies
- poudre pour solution injectable1 products
- 50 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.